Garcinone E suppresses breast cancer growth and metastasis by modulating tumor‐associated macrophages polarization via STAT6 signaling

Abstract Cancer metastasis remains the most common cause of death in breast cancer patients. Tumor‐associated macrophages (TAMs) are a novel therapeutic target for the treatment of metastatic breast cancer. Despite the good anti‐cancer activity of garcinone E (GE), there are no reports on its therapeutic effects on breast cancer metastasis. The objective of this study was to examine the anti‐cancer effects of GE on metastatic breast cancer. RAW 264.7 and THP‐1 cells were polarized to M2 macrophages by IL‐4/IL‐13 in vitro. A 4T1 mouse breast cancer model and the tail vein breast cancer metastasis model were used to explore the effect of GE on breast cancer growth and metastasis in vivo. In vitro studies showed that GE dose‐dependently suppressed IL‐4 + IL‐13‐induced expression of CD206 in both RAW 264.7 cells and differentiated THP‐1 macrophages. However, GE did not affect the LPS + IFN‐γ‐induced polarization to the M1‐like macrophages in vitro. GE inhibited the expression of the M2 macrophage specific genes in RAW 264.7 cells, and simultaneously impaired M2 macrophage‐induced breast cancer cell proliferation and migration, and angiogenesis. In animal studies, GE significantly suppressed tumor growth, angiogenesis, and lung metastasis in 4T1 tumor‐bearing mice, without causing toxicity. In both tumor and lung tissues, the proportion of M2‐like TAMs was significantly decreased while the proportion of M1‐like TAMs was markedly increased by GE treatment. Mechanistically, GE inhibited phosphorylation of STAT6 in vitro and in vivo. Our results demonstrate for the first time that GE suppresses breast cancer growth and pulmonary metastasis by modulating M2‐like macrophage polarization through the STAT6 signaling pathway.